Nasdaq · CIK 0000874716
IDXX IDEXX LABORATORIES INC /DE
Insider trading from SEC Form 4. Last filing 33 d ago. Close $518.00 on Oct 9, 2026, +3% from the 52-week low and -32% from the high.
Last 90 days
Net insider value
-$1.2M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$1.2M by 1 insider
Insiders on file
16
with a Form 4 at this company
Price and insider trades, last year
IDXXOct 9, 2026 · close 518.00
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at IDEXX LABORATORIES INC /DE, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Lawrence D Kingsley director sell | $1.2M 2,203 shares | -19% | - | |
| 53Moderate | George Fennell Executive Vice President sell | $4.6M 9,986 shares | -55% | - | |
| 58Moderate | M Anne Szostak director sell | $1.4M 3,000 shares | -49% | - | |
| 36Weak | Sophie V. Vandebroek director sell | $145k 344 shares | -28% | - |
Congressional trades
17 trades in IDXX disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
April McClain Delaney House · D-MD | Sale | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Jan 13 / Feb 2 20 days after the trade | Clerk |
April McClain Delaney House · D-MD | Partial sale | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Oct 16, 2025 / Nov 4, 2025 19 days after the trade | Clerk |
Byron Donalds House · R-FL | Purchase | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Sep 4, 2025 / Oct 7, 2025 33 days after the trade | Clerk |
Byron Donalds House · R-FL | Purchase | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Sep 4, 2025 / Oct 7, 2025 33 days after the trade | Clerk |
April McClain Delaney House · D-MD | Partial sale | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Aug 7, 2025 / Sep 2, 2025 26 days after the trade | Clerk |
April McClain Delaney House · D-MD | Partial sale | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Jul 9, 2025 / Aug 5, 2025 27 days after the trade | Clerk |
Jefferson Shreve House · R-IN | Sale | IDXX IDEXX Laboratories, Inc. - Common Stock | $100k to $250k | May 12, 2025 / Jun 22, 2025 41 days after the trade | Clerk |
Robert P. Bresnahan, Jr. House · R-PA | Purchase | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | May 15, 2025 / Jun 9, 2025 25 days after the trade | Clerk |
Jefferson Shreve House · R-IN | Purchase | IDXX IDEXX Laboratories, Inc. - Common Stock | $50k to $100k | Apr 7, 2025 / May 8, 2025 31 days after the trade | Clerk |
April McClain Delaney House · D-MD | Purchase | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Apr 7, 2025 / May 2, 2025 25 days after the trade | Clerk |
April McClain Delaney House · D-MD | Purchase | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Apr 4, 2025 / May 2, 2025 28 days after the trade | Clerk |
April McClain Delaney House · D-MD | Purchase | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Apr 1, 2025 / May 2, 2025 31 days after the trade | Clerk |
April McClain Delaney House · D-MD | Purchase | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Apr 9, 2025 / May 2, 2025 23 days after the trade | Clerk |
Robert P. Bresnahan, Jr. House · R-PA | Sale | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Apr 8, 2025 / Apr 28, 2025 20 days after the trade | Clerk |
Jefferson Shreve House · R-IN | Purchase | IDXX IDEXX Laboratories, Inc. - Common Stock | $15k to $50k | Mar 13, 2025 / Apr 11, 2025 29 days after the trade | Clerk |
April McClain Delaney House · D-MD | Purchase | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Mar 14, 2025 / Apr 2, 2025 19 days after the trade | Clerk |
Robert P. Bresnahan, Jr. House · R-PA | Purchase | IDXX IDEXX Laboratories, Inc. - Common Stock | $1,001 to $15k | Feb 25, 2025 / Mar 27, 2025 30 days after the trade | Clerk |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Lawrence D Kingsley director | MOption exercise Common Stock | +2,203 | $114.17 | $252k | 11,771 | 33 d ago |
| Sep 4, 2026 | Lawrence D Kingsley director | SOpen-market sale Common Stock | -2,203 | $532.08 | $1.2M | 9,568 | 33 d ago |
| Sep 4, 2026 | Lawrence D Kingsley director | MOption exercise Non-Qualified Stock Option (right-to-buy)derivative | -2,203 | - | - | 0 | 33 d ago |
| May 7, 2025 | Bruce L. Claflin director | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +600 | $0.00 | $0 | 600 | May 8, 2025 |
| May 7, 2025 | Irene Chang Britt director | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +600 | $0.00 | $0 | 600 | May 8, 2025 |
| May 6, 2025 | Stuart Essig director | MOption exercise Common Stock | +262 | $0.00 | $0 | 2,236 | May 8, 2025 |
| May 7, 2025 | Irene Chang Britt director | AGrant or award Deferred Stock Unitderivative | +257 | $0.00 | $0 | 257 | May 8, 2025 |
| May 6, 2025 | Stuart Essig director | MOption exercise Restricted Stock Unitderivative | -262 | $0.00 | $0 | 0 | May 8, 2025 |
| May 7, 2025 | Bruce L. Claflin director | AGrant or award Deferred Stock Unitderivative | +257 | $0.00 | $0 | 257 | May 8, 2025 |
| May 7, 2025 | Stuart Essig director | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +600 | $0.00 | $0 | 600 | May 8, 2025 |
| May 7, 2025 | Stuart Essig director | AGrant or award Deferred Stock Unitderivative | +257 | $0.00 | $0 | 257 | May 8, 2025 |
| Feb 14, 2025 | Jonathan Jay Mazelsky President and CEO | MOption exercise Common Stock | +689 | $0.00 | $0 | 82,447 | Feb 18, 2025 |
| Feb 14, 2025 | Michael G Erickson Executive Vice President | MOption exercise Common Stock | +69 | $0.00 | $0 | 20,905 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Perkins Johnson Executive Vice President | MOption exercise Common Stock | +176 | $0.00 | $0 | 406 | Feb 18, 2025 |
| Feb 14, 2025 | Martin Alexander Smith Executive Vice President | MOption exercise Common Stock | +148 | $0.00 | $0 | 683 | Feb 18, 2025 |
| Feb 14, 2025 | Sharon E. Underberg EVP, GC & Corporate Secretary | AGrant or award Common Stock | +137 | $0.00 | $0 | 5,779 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Schreck Executive Vice President | MOption exercise Common Stock | +80 | $0.00 | $0 | 1,018 | Feb 18, 2025 |
| Feb 14, 2025 | Brian P McKeon EVP, CFO and Treasurer | MOption exercise Common Stock | +252 | $0.00 | $0 | 31,209 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Lane Executive Vice President | MOption exercise Common Stock | +160 | $0.00 | $0 | 6,650 | Feb 18, 2025 |
| Feb 14, 2025 | George Fennell Executive Vice President | MOption exercise Common Stock | +51 | $0.00 | $0 | 8,227 | Feb 18, 2025 |
| Feb 14, 2025 | Nimrata Hunt Executive Vice President | MOption exercise Common Stock | +160 | $0.00 | $0 | 11,883 | Feb 18, 2025 |
| Feb 14, 2025 | Martin Alexander Smith Executive Vice President | MOption exercise Common Stock | +593 | $0.00 | $0 | 1,276 | Feb 18, 2025 |
| Feb 14, 2025 | George Fennell Executive Vice President | MOption exercise Common Stock | +56 | $0.00 | $0 | 8,283 | Feb 18, 2025 |
| Feb 14, 2025 | Nimrata Hunt Executive Vice President | MOption exercise Common Stock | +204 | $0.00 | $0 | 12,087 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Lane Executive Vice President | MOption exercise Common Stock | +204 | $0.00 | $0 | 6,854 | Feb 18, 2025 |
| Feb 14, 2025 | Brian P McKeon EVP, CFO and Treasurer | MOption exercise Common Stock | +303 | $0.00 | $0 | 31,512 | Feb 18, 2025 |
| Feb 14, 2025 | Michael G Erickson Executive Vice President | MOption exercise Common Stock | +93 | $0.00 | $0 | 20,998 | Feb 18, 2025 |
| Feb 14, 2025 | Sharon E. Underberg EVP, GC & Corporate Secretary | AGrant or award Common Stock | +173 | $0.00 | $0 | 5,952 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Perkins Johnson Executive Vice President | MOption exercise Common Stock | +179 | $0.00 | $0 | 585 | Feb 18, 2025 |
| Feb 14, 2025 | Jonathan Jay Mazelsky President and CEO | MOption exercise Common Stock | +958 | $0.00 | $0 | 83,405 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Schreck Executive Vice President | MOption exercise Common Stock | +117 | $0.00 | $0 | 1,135 | Feb 18, 2025 |
| Feb 14, 2025 | Nimrata Hunt Executive Vice President | MOption exercise Common Stock | +207 | $0.00 | $0 | 12,294 | Feb 18, 2025 |
| Feb 14, 2025 | Sharon E. Underberg EVP, GC & Corporate Secretary | AGrant or award Common Stock | +176 | $0.00 | $0 | 6,128 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Lane Executive Vice President | MOption exercise Common Stock | +220 | $0.00 | $0 | 7,074 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Perkins Johnson Executive Vice President | FTax withholding Common Stock | -118 | $444.53 | $52k | 467 | Feb 18, 2025 |
| Feb 14, 2025 | Martin Alexander Smith Executive Vice President | MOption exercise Common Stock | +189 | $0.00 | $0 | 1,465 | Feb 18, 2025 |
| Feb 14, 2025 | Brian P McKeon EVP, CFO and Treasurer | MOption exercise Common Stock | +308 | $0.00 | $0 | 31,820 | Feb 18, 2025 |
| Feb 14, 2025 | George Fennell Executive Vice President | MOption exercise Common Stock | +57 | $0.00 | $0 | 8,340 | Feb 18, 2025 |
| Feb 14, 2025 | Jonathan Jay Mazelsky President and CEO | MOption exercise Common Stock | +1,100 | $0.00 | $0 | 84,505 | Feb 18, 2025 |
| Feb 14, 2025 | Michael G Erickson Executive Vice President | MOption exercise Common Stock | +94 | $0.00 | $0 | 21,092 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Schreck Executive Vice President | MOption exercise Common Stock | +791 | $0.00 | $0 | 1,926 | Feb 18, 2025 |
| Feb 13, 2025 | Michael Perkins Johnson Executive Vice President | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +3,657 | $0.00 | $0 | 3,657 | Feb 18, 2025 |
| Feb 14, 2025 | Nimrata Hunt Executive Vice President | MOption exercise Common Stock | +301 | $0.00 | $0 | 12,595 | Feb 18, 2025 |
| Feb 14, 2025 | Martin Alexander Smith Executive Vice President | MOption exercise Common Stock | +301 | $0.00 | $0 | 1,766 | Feb 18, 2025 |
| Feb 14, 2025 | George Fennell Executive Vice President | MOption exercise Common Stock | +140 | $0.00 | $0 | 8,480 | Feb 18, 2025 |
| Feb 14, 2025 | Sharon E. Underberg EVP, GC & Corporate Secretary | AGrant or award Common Stock | +218 | $0.00 | $0 | 6,346 | Feb 18, 2025 |
| Feb 14, 2025 | Brian P McKeon EVP, CFO and Treasurer | MOption exercise Common Stock | +299 | $0.00 | $0 | 32,119 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Lane Executive Vice President | MOption exercise Common Stock | +301 | $0.00 | $0 | 7,375 | Feb 18, 2025 |
| Feb 14, 2025 | Jonathan Jay Mazelsky President and CEO | FTax withholding Common Stock | -1,222 | $444.53 | $543k | 83,283 | Feb 18, 2025 |
| Feb 14, 2025 | Michael G Erickson Executive Vice President | MOption exercise Common Stock | +301 | $0.00 | $0 | 21,393 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Schreck Executive Vice President | MOption exercise Common Stock | +170 | $0.00 | $0 | 2,096 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Schreck Executive Vice President | MOption exercise Common Stock | +301 | $0.00 | $0 | 2,397 | Feb 18, 2025 |
| Feb 14, 2025 | Michael G Erickson Executive Vice President | FTax withholding Common Stock | -177 | $444.53 | $79k | 21,216 | Feb 18, 2025 |
| Feb 14, 2025 | Nimrata Hunt Executive Vice President | FTax withholding Common Stock | -268 | $444.53 | $119k | 12,327 | Feb 18, 2025 |
| Feb 13, 2025 | Michael Perkins Johnson Executive Vice President | AGrant or award Incentive Stock Option (right-to-buy)derivative | +217 | $0.00 | $0 | 217 | Feb 18, 2025 |
| Feb 14, 2025 | Martin Alexander Smith Executive Vice President | FTax withholding Common Stock | -374 | $444.53 | $166k | 1,392 | Feb 18, 2025 |
| Feb 13, 2025 | Jonathan Jay Mazelsky President and CEO | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +25,932 | $0.00 | $0 | 25,932 | Feb 18, 2025 |
| Feb 14, 2025 | Sharon E. Underberg EVP, GC & Corporate Secretary | FTax withholding Common Stock | -219 | $444.53 | $97k | 6,127 | Feb 18, 2025 |
| Feb 14, 2025 | Brian P McKeon EVP, CFO and Treasurer | FTax withholding Common Stock | -569 | $444.53 | $253k | 31,550 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Lane Executive Vice President | FTax withholding Common Stock | -272 | $444.53 | $121k | 7,103 | Feb 18, 2025 |
| Feb 14, 2025 | George Fennell Executive Vice President | FTax withholding Common Stock | -133 | $444.53 | $59k | 8,347 | Feb 18, 2025 |
| Feb 13, 2025 | Sharon E. Underberg EVP, GC & Corporate Secretary | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +4,504 | $0.00 | $0 | 4,504 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Schreck Executive Vice President | FTax withholding Common Stock | -441 | $444.53 | $196k | 1,956 | Feb 18, 2025 |
| Feb 13, 2025 | Jonathan Jay Mazelsky President and CEO | AGrant or award Incentive Stock Option (right-to-buy)derivative | +217 | $0.00 | $0 | 217 | Feb 18, 2025 |
| Feb 13, 2025 | George Fennell Executive Vice President | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +3,415 | $0.00 | $0 | 3,415 | Feb 18, 2025 |
| Feb 13, 2025 | Michael Perkins Johnson Executive Vice President | AGrant or award Restricted Stock Unitderivative | +870 | $0.00 | $0 | 870 | Feb 18, 2025 |
| Feb 13, 2025 | Michael G Erickson Executive Vice President | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +6,320 | $0.00 | $0 | 6,320 | Feb 18, 2025 |
| Feb 13, 2025 | Martin Alexander Smith Executive Vice President | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +6,320 | $0.00 | $0 | 6,320 | Feb 18, 2025 |
| Feb 13, 2025 | Sharon E. Underberg EVP, GC & Corporate Secretary | AGrant or award Incentive Stock Option (right-to-buy)derivative | +217 | $0.00 | $0 | 217 | Feb 18, 2025 |
| Feb 13, 2025 | Michael Schreck Executive Vice President | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +6,320 | $0.00 | $0 | 6,320 | Feb 18, 2025 |
| Feb 13, 2025 | George Fennell Executive Vice President | AGrant or award Incentive Stock Option (right-to-buy)derivative | +217 | $0.00 | $0 | 217 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Perkins Johnson Executive Vice President | MOption exercise Restricted Stock Unitderivative | -176 | $0.00 | $0 | 352 | Feb 18, 2025 |
| Feb 14, 2025 | Brian P McKeon EVP, CFO and Treasurer | MOption exercise Restricted Stock Unitderivative | -252 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 13, 2025 | Michael G Erickson Executive Vice President | AGrant or award Incentive Stock Option (right-to-buy)derivative | +217 | $0.00 | $0 | 217 | Feb 18, 2025 |
| Feb 13, 2025 | Michael Lane Executive Vice President | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +6,320 | $0.00 | $0 | 6,320 | Feb 18, 2025 |
| Feb 14, 2025 | Jonathan Jay Mazelsky President and CEO | MOption exercise Restricted Stock Unitderivative | -689 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 13, 2025 | Martin Alexander Smith Executive Vice President | AGrant or award Incentive Stock Option (right-to-buy)derivative | +217 | $0.00 | $0 | 217 | Feb 18, 2025 |
| Feb 13, 2025 | Nimrata Hunt Executive Vice President | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +6,320 | $0.00 | $0 | 6,320 | Feb 18, 2025 |
| Feb 13, 2025 | Martin Alexander Smith Executive Vice President | AGrant or award Restricted Stock Unitderivative | +1,468 | $0.00 | $0 | 1,468 | Feb 18, 2025 |
| Feb 13, 2025 | Sharon E. Underberg EVP, GC & Corporate Secretary | AGrant or award Restricted Stock Unitderivative | +1,060 | $0.00 | $0 | 1,060 | Feb 18, 2025 |
| Feb 13, 2025 | Nimrata Hunt Executive Vice President | AGrant or award Incentive Stock Option (right-to-buy)derivative | +217 | $0.00 | $0 | 217 | Feb 18, 2025 |
| Feb 13, 2025 | Michael G Erickson Executive Vice President | AGrant or award Restricted Stock Unitderivative | +734 | $0.00 | $0 | 734 | Feb 18, 2025 |
| Feb 13, 2025 | Michael Schreck Executive Vice President | AGrant or award Incentive Stock Option (right-to-buy)derivative | +217 | $0.00 | $0 | 217 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Perkins Johnson Executive Vice President | MOption exercise Restricted Stock Unitderivative | -179 | $0.00 | $0 | 535 | Feb 18, 2025 |
| Feb 14, 2025 | Brian P McKeon EVP, CFO and Treasurer | MOption exercise Restricted Stock Unitderivative | -303 | $0.00 | $0 | 303 | Feb 18, 2025 |
| Feb 13, 2025 | Michael Lane Executive Vice President | AGrant or award Incentive Stock Option (right-to-buy)derivative | +217 | $0.00 | $0 | 217 | Feb 18, 2025 |
| Feb 13, 2025 | George Fennell Executive Vice President | AGrant or award Restricted Stock Unitderivative | +816 | $0.00 | $0 | 816 | Feb 18, 2025 |
| Feb 14, 2025 | Jonathan Jay Mazelsky President and CEO | MOption exercise Restricted Stock Unitderivative | -958 | $0.00 | $0 | 958 | Feb 18, 2025 |
| Feb 13, 2025 | Michael Lane Executive Vice President | AGrant or award Restricted Stock Unitderivative | +1,468 | $0.00 | $0 | 1,468 | Feb 18, 2025 |
| Feb 14, 2025 | Martin Alexander Smith Executive Vice President | MOption exercise Restricted Stock Unitderivative | -148 | $0.00 | $0 | 148 | Feb 18, 2025 |
| Feb 14, 2025 | Sharon E. Underberg EVP, GC & Corporate Secretary | MOption exercise Restricted Stock Unitderivative | -137 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 14, 2025 | Brian P McKeon EVP, CFO and Treasurer | MOption exercise Restricted Stock Unitderivative | -308 | $0.00 | $0 | 615 | Feb 18, 2025 |
| Feb 13, 2025 | Michael Schreck Executive Vice President | AGrant or award Restricted Stock Unitderivative | +1,468 | $0.00 | $0 | 1,468 | Feb 18, 2025 |
| Feb 13, 2025 | Nimrata Hunt Executive Vice President | AGrant or award Restricted Stock Unitderivative | +1,468 | $0.00 | $0 | 1,468 | Feb 18, 2025 |
| Feb 13, 2025 | Michael G Erickson Executive Vice President | AGrant or award Restricted Stock Unitderivative | +734 | $0.00 | $0 | 734 | Feb 18, 2025 |
| Feb 14, 2025 | George Fennell Executive Vice President | MOption exercise Restricted Stock Unitderivative | -51 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 14, 2025 | Jonathan Jay Mazelsky President and CEO | MOption exercise Restricted Stock Unitderivative | -1,100 | $0.00 | $0 | 2,198 | Feb 18, 2025 |
| Feb 14, 2025 | Michael Schreck Executive Vice President | MOption exercise Restricted Stock Unitderivative | -80 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 14, 2025 | Michael G Erickson Executive Vice President | MOption exercise Restricted Stock Unitderivative | -69 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 14, 2025 | Nimrata Hunt Executive Vice President | MOption exercise Restricted Stock Unitderivative | -160 | $0.00 | $0 | 0 | Feb 18, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Irene Chang Brittdirector
- Bruce L. Claflindirector
- Stuart Essigowner, director, chair, officer
- Michael G EricksonExecutive Vice President
- George FennellExecutive Vice President
- Nimrata HuntExecutive Vice President
- Michael Perkins JohnsonExecutive Vice President
- Lawrence D Kingsleydirector
- Michael LaneExecutive Vice President
- Jonathan Jay MazelskyPresident and CEO
- Brian P McKeonEVP, CFO and Treasurer
- M Anne Szostakdirector
- Michael SchreckExecutive Vice President
- Martin Alexander SmithExecutive Vice President
- Sharon E. UnderbergEVP, GC & Corporate Secretary
- Sophie V. Vandebroekdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.